Zoloft Caused Heart Defects In Newborn, Philly Jury Hears

By Matt Fair (June 1, 2015, 5:09 PM EDT) -- A second trial against Pfizer Inc. over alleged birth defects caused by the antidepressant Zoloft got underway Monday as a state jury in Philadelphia heard arguments that the pharmaceutical giant had failed to provide adequate warnings about the drug to the mother of a baby born with serious heart problems.

Clark Love & Hutson GP attorney Scott Love told a jury that eight-year-old Mia Robinson had been born with a congenital heart defect after Pfizer failed to share information with her mother's prescribing physician about the risks associated with Zoloft.

"This is a case about a company that knew their drug...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!